What's new

Human medicines European public assessment report (EPAR): LysaKare, arginine,lysine, Date of authorisation: 25/07/2019, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR): LysaKare, arginine,lysine, Date of authorisation: 25/07/2019, Revision: 7, Status: Authorised

Apr 28, 2025 - 14:54
 0
Human medicines European public assessment report (EPAR): LysaKare, arginine,lysine, Date of authorisation: 25/07/2019, Revision: 7, Status: Authorised
Human medicines European public assessment report (EPAR): LysaKare, arginine,lysine, Date of authorisation: 25/07/2019, Revision: 7, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Bimzelx, bimekizumab, ...

Next Article

Bangladesh plans 2 new exclusive economic zones for Chinese investors

Related Posts

Human medicines European public assessment report (EPAR): Regkirona, regdanvimab, Date of authorisation: 12/11/2021, Revision: 9, Status: Withdrawn

Human medicines European public assessment report (EPAR...

Apr 24, 2025  0

Human medicines European public assessment report (EPAR): Tysabri, natalizumab, Date of authorisation: 27/06/2006, Revision: 47, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 23, 2025  0

Human medicines European public assessment report (EPAR): Dyrupeg, pegfilgrastim, Date of authorisation: 28/03/2025, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 25, 2025  0